albuterol sulfate; budesonide · Astrazeneca · NDA 214070
Airsupra
Earliest generic entry, as listed
28 May 2030
Blocked by patent: US 9415009. Only method-of-use patents remain, so a generic may carve out the protected indication and enter earlier.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9415009 | use U-3509 | 28 May 2030 |
Exclusivities · 1 unexpired
| M-317 | miscellaneous (3 years) | 15 Sep 2028 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 214070 · 001 · RLD | aerosol, metered, inhalation | EQ 0.09MG BASE/INH;0.08MG/INH | 28 May 2030 |
Expired or delisted (1)
- NP · 10 Jan 2026